Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Scope Of FDA’s Home-Use Device Draft Guidance Is Too Broad, Industry Says

This article was originally published in The Gray Sheet

Executive Summary

Many of the comments on FDA's draft guidance on design considerations for devices intended for home use voiced concerns about the expansive scope of the document.

You may also be interested in...



FDA Finalizes Home-Use Device Guidance, Consistent With Draft

The agency issued guidelines on designing devices for the home, sticking with most of its 2012 draft, despite complaints from industry.

Final Home-Use Device Guidance Expected Mostly ‘As Is’ By Year’s End

Representatives of home health care and device companies, hospital staff, home health care professionals, device standard-setting groups and consultants put together a draft priority list of challenges and solutions for home-use devices at an Association for the Advancement of Medical Instrumentation summit meeting earlier this month, anticipating finalized FDA guidance by the end of the year.

Draft Guidance Tackles Common Errors In Adverse Event Reporting

A revised guidance on medical device reporting fleshes out FDA’s thinking on manufacturers’ responsibilities in various situations.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031918

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel